Patent: 7,279,320
✉ Email this page to a colleague
Summary for Patent: 7,279,320
| Title: | Curlicue vaccine strain of Bacillus anthracis |
| Abstract: | A new strain of Bacillus anthracis derived from the Sterne vaccine strain of Bacillus anthracis by growth on a high-nitrate-concentration, 3-amino-L-tyrosine growth medium. |
| Inventor(s): | Parker; Jill E. (Floresville, TX), Kiel; Johnathan L. (Universal City, TX), Gifford; Homer (Hardy, AR), Morales, legal representative; Pedro J. (Floresville, TX), Alls, deceased; John L. (Floresville, TX) |
| Assignee: | United States as represented by the Secretary of the Air Force (Washington, DC) |
| Application Number: | 10/828,630 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,279,320
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Emergent Biodefense Operations Lansing Llc | BIOTHRAX | anthrax vaccine adsorbed | Injection | 103821 | 11/12/1998 | ⤷ Try a Trial | 2023-06-20 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
